申请人:MORGAN Philip F.
公开号:US20100311727A1
公开(公告)日:2010-12-09
Therapeutic amine-arylsulfonamide conjugate compounds, of the general formula:
wherein
R′ is [D-W-], hydroxyl, or alkoxyl;
R″ is independently [D-W′-], hydrogen, alkoxy, alkyl, cycloalkyl, alkenyl, alkynyl or aryl, or R″ and R″ together with the nitrogen atom to which they are attached form a 4-, 5-, 6-, 7- or 8-membered ring optionally containing one or two further heteroatoms independently selected from nitrogen, oxygen and sulfur;
D is independently a therapeutic amine radical comprising at least one nitrogen atom and optionally at least one oxygen atom coupled to W or W′ by a nitrogen or oxygen atom;
W and W′ are a chemical bond or linker;
wherein either R′ is [D-W-] or at least one R″ is [D-W′-],
and pharmaceutically acceptable esters, amides, salts or solvates thereof, pharmaceutical compositions containing same, methods for their preparation, and their use in treating psychiatric, neurologic and metabolic disorders are disclosed.
治疗性胺基-芳基磺酰胺偶联化合物,一般式如下:其中,R′为[D-W-]、羟基或烷氧基;R″独立地为[D-W′-]、氢、烷氧基、烷基、环烷基、烯基、炔基或芳基,或R″和与它们连接的氮原子一起形成一个含有1或2个来自氮、氧和硫的进一步杂原子的4、5、6、7或8元环,D独立地为治疗性胺基基团,包括至少一个氮原子,通过氮或氧原子与W或W'耦合,W和W'为化学键或连接基,其中R′为[D-W-]或至少一个R″为[D-W′-],以及其药学上可接受的酯、酰胺、盐或溶剂化物,包含它们的制备方法,以及它们用于治疗精神病、神经病和代谢疾病的用途。